These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 370017)

  • 1. Strain specificity of opsonins for group B streptococci types II and III.
    Shigeoka AO; Hall RT; Hill HR
    Infect Immun; 1979 Feb; 23(2):438-45. PubMed ID: 370017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of the Ibc protein antigen to the opsonization differences between strains of type II group B streptococci.
    Payne NR; Ferrieri P
    J Infect Dis; 1985 Apr; 151(4):672-81. PubMed ID: 3882857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antibody and complement in opsonization of group B streptococci.
    Shigeoka AO; Hall RT; Hemming VG; Allred CD; Hill HR
    Infect Immun; 1978 Jul; 21(1):34-40. PubMed ID: 101462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in the opsonic requirements of group B streptococcus type III.
    Hastings MJ; Easmon CS
    Br J Exp Pathol; 1981 Oct; 62(5):519-25. PubMed ID: 7028075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.
    Fischer GW; Hunter KW; Wilson SR
    Pediatr Res; 1981 Dec; 15(12):1525-9. PubMed ID: 7033908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.
    Edwards MS; Baker CJ; Kasper DL
    J Infect Dis; 1979 Dec; 140(6):1004-8. PubMed ID: 396335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.
    Payne NR; Kim YK; Ferrieri P
    Infect Immun; 1987 May; 55(5):1243-51. PubMed ID: 3552996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodeterminant specificity of human immunity to type III group B streptococcus.
    Kasper DL; Baker CJ; Baltimore RS; Crabb JH; Schiffman G; Jennings HJ
    J Exp Med; 1979 Feb; 149(2):327-39. PubMed ID: 84042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ingestion and killing of Streptococcus agalactiae by bovine granulocytes in the presence of natural opsonins.
    Rainard P; Lautrou Y; Poutrel B
    Vet Microbiol; 1988 Sep; 18(1):41-50. PubMed ID: 3055659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological specificity of heat-stable opsonins in immune and nonimmune sera and their interaction with non-encapsulated and encapsulated strains of Staphylococcus aureus.
    Karakawa WW; Young DA
    Infect Immun; 1979 Jul; 25(1):175-86. PubMed ID: 478633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.
    Hemming VG; Hall RT; Rhodes PG; Shigeoka AO; Hill HR
    J Clin Invest; 1976 Dec; 58(6):1379-87. PubMed ID: 62761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
    Rainard P; Sarradin P; Poutrel B
    Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological specificity of natural opsonins and their role in the cross-reactivity between Staphylococcus aureus Mardi and Escherichia coli 101.
    Young DA; Dobson P; Karakawa WW
    Infect Immun; 1979 Sep; 25(3):954-9. PubMed ID: 91583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological stabilization of capsules of group B streptococci, types Ia, Ib, II, and III, with specific antibody.
    Mackie EB; Brown KN; Lam J; Costerton JW
    J Bacteriol; 1979 May; 138(2):609-17. PubMed ID: 374399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.
    Rainard P; Boulard C
    Infect Immun; 1992 Nov; 60(11):4801-8. PubMed ID: 1398991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity elicited by the beta C protein of group B streptococci contrasted with capsular polysaccharides.
    Fusco PC; Perry JW; Liang SM; Blake MS; Michon F; Tai JY
    Adv Exp Med Biol; 1997; 418():841-5. PubMed ID: 9331784
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.
    Baltimore RS; Kasper DL; Baker CJ; Goroff DK
    J Immunol; 1977 Feb; 118(2):673-8. PubMed ID: 65433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of experimental conjugated and combined vaccines against group B streptococci].
    Ditina MA; Meringova LF; Leont'eva GF; Frabovskaia KB; Yang A; Shen Z; Suvorov AN
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (1):37-41. PubMed ID: 19338234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.
    Wessels MR; Paoletti LC; Kasper DL; DiFabio JL; Michon F; Holme K; Jennings HJ
    J Clin Invest; 1990 Nov; 86(5):1428-33. PubMed ID: 2243123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.